Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

RiverVest Venture Partners Closes Life Sciences Fund With $275 Million

Posted in Life Sciences Investing

RiverVest Venture Partners has announced it has closed its fifth fund — RiverVest Venture Fund V — with $275 million of capital commitments.

RiverVest, based in St. Louis, Mo., is a venture capital firm that targets investments in early-stage biopharma and medical device companies.

Fund V is RiverVest’s largest fund to date. With the fifth fund, which was oversubscribed, RiverVest’s total assets under management now exceed $1.6 billion.

The firm noted that it has invested in 55 companies and founded 15 companies.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.